Peer-reviewed veterinary case report
Firocoxib NSAID improves osteoarthritis in 1,000 dogs safely
By Ryan, William G et al.·Published in Veterinary therapeutics : research in applied veterinary medicine·2006·Ryan Mitchell Associates, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Clinical effectiveness and safety of a new NSAID, firocoxib: a 1,000 dog study.
- Species:
- dog
Plain-English summary
A study involving over 1,000 dogs with osteoarthritis (OA) found that a new pain relief medication called firocoxib (Previcox) was effective and safe for treating joint pain. Most dog owners reported that their pets were happier and more active after starting the treatment, with 93% of veterinarians and 91% of owners noticing improvements. The side effects were minimal, with only a small percentage of dogs experiencing gastrointestinal issues. Overall, firocoxib proved to be a well-tolerated option for managing pain in dogs with OA.
People also search for: dog arthritis treatment · firocoxib for dogs · osteoarthritis in dogs symptoms
Abstract
For the Previcox (firocoxib, Merial) Experience Trial, practicing veterinarians across the United States were asked to enroll dogs diagnosed with osteoarthritis (OA). At an initial visit, owners of dogs deemed suitable for NSAID therapy were given Previcox and instructed to maintain a daily diary and to return 10 and 40 days after treatment began. Approximately 86% of the 1,002 enrolled dogs completed the study. The withdrawal rate associated with gastrointestinal side effects was low (2.9% of dogs), and no serious drug-related adverse events were reported. Investigators and Owners rated 93% and 91% of dogs, respectively, as improved, and 86% of owners rated their dogs "happier" or "more active" after treatment with firocoxib. The improvements observed following initiation of firocoxib therapy were independent of gender, breed, starting body weight, age, and prior NSAID use. These results support previous findings indicating that firocoxib is well tolerated and effective when used under field conditions.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/16871494/